Yizhen Liu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Clinical Impact of BTK Inhibitor Exposure in LymphGen-Defined MCD Diffuse Large B-Cell Lymphoma.
Journal: Hematological oncology
Published: June 04, 2026
Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.
Journal: Blood cancer journal
Published: January 01, 2026
HERVH-derived eRNA activates a super-enhancer-driven ALDH1A3/SAT1 axis to promote ferroptosis escape and pancreatic cancer development.
Journal: Science advances
Published: December 10, 2025
Selinexor combined with R-GDP as salvage therapy in relapsed/refractory diffuse large B-cell lymphoma.
Journal: American journal of cancer research
Published: September 06, 2025
Elevated FGR protein expression identifies a high-risk subset of diffuse large B-cell lymphoma and a potential therapeutic target.
Journal: Frontiers in oncology
Published: August 19, 2025
Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial.
Journal: Blood cancer journal
Published: October 04, 2024
Prognostic Significance of Deubiquitinase OTUD7B in NK/T-Cell Lymphoma.
Journal: Asia-Pacific journal of clinical oncology
Published: July 22, 2024
Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-β-catenin axis in modulating gemcitabine resistance in pancreatic cancer.
Journal: Cancer letters
Published: June 07, 2024
Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study.
Journal: Cancer medicine
Published: February 05, 2024
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB.
Journal: International journal of hematology
Published: January 27, 2024
Transposable elements-mediated recruitment of KDM1A epigenetically silences HNF4A expression to promote hepatocellular carcinoma.
Journal: Nature communications
Published: September 12, 2023
POH1 facilitates pancreatic carcinogenesis through MYC-driven acinar-to-ductal metaplasia and is a potential therapeutic target.
Journal: Cancer letters
Published: July 25, 2023
Last Updated: 09/26/2026